Keep Informed on Legal and Compliance Developments Affecting Diagnostic Labs
Best practices and expert insight to help lab professionals comply with regulations and identify strategic trends in business and technology
Already a Subscriber? Log in Here
Lab Industry Advisor Subscription
Struggling with Staying Informed? In the fast-paced world of diagnostic medicine, staying updated with the latest legal, compliance, regulatory, and industry insights is crucial. Yet, finding reliable and comprehensive information can be overwhelming and time-consuming.
Lab Industry Advisor to the Rescue! Lab Industry Advisor provides comprehensive, up-to-date insights and analyses tailored to your needs. With expert commentary and actionable advice, you’ll stay ahead of the curve. No more sifting through endless sources—everything you need is right here!
Start your free trial today and see how Lab Industry Advisor can transform your approach. Get instant access to invaluable resources designed to keep you informed and competitive. Explore detailed reports, in-depth articles, and exclusive industry insights that help you make better decisions faster. Choose from three subscription levels tailored to fit your needs: Essential, Premium, and Elite.
Additional Business Intelligence Offerings
Clinical Diagnostics Insider
Keeps you up-to-date on new diagnostic tests, testing trends and opportunities, and emerging test technologies
Virtual Events & Webinars
Virtual events & webinars offer a variety of solutions and strategies for dealing with key issues labs face.
Lab Industry Advisor Subscriptions Include
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Latest Articles
LDTs Rule Update: More Support for Legal Challenges Against FDA
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
New FDA LDTs Guidance Offers Useful Summary, But Questions Remain
Recently released document for small labs offers a more digestible version of the final rule requirements but still lacks key details
CMS Slated to Close Change Healthcare Payment Program
Program meant to ease cash flow disruptions experienced by some Medicare providers and suppliers due to the cyberattack will conclude in mid-July
Faster Genome Analysis Enabling Clinical Application, Population-Scale Translational Research
...
Register
Genomic Testing Making Inroads in Cardiology
...
Register
In-Field Lactate Testing Could Improve Trauma Patient Triage
...
Register
Unnecessary Testing Occurs Before Cataract Surgery
...
Register
Pioneer ACOs Reduce Utilization, Stem Spending Without Compromising Care, Study Finds
By Stephanie Murg, Managing Director, G2 Intelligence The first wave of accountable care organizations (ACOs) is positioned well to achieve the touted goal of "bending the cost curve," according to a study published May 4 in the online edition of the Journal of the...
IBM’s Watson to Speed Genomic Analysis, Personalized Cancer Care
By Lori Solomon, Editor, Diagnostic Testing & Emerging Technologies Fourteen specialized cancer institutes will utilize IBM's Watson computing system to improve personalized oncology care, according to an announcement IBM made as part of the World of Watson...
New Platform Helps Labs Comply with Patient Access Requirements
By Kelly A. Briganti, Editorial Director, G2 Intelligence Psyche Systems Corporation (Milford, MA), a laboratory information software company, and Luminate Health (San Francisco, CA), a provider of web-based services, have entered into a "strategic alliance" to...
Invivoscribe, Astellas Enter Into Pact for Leukemia Testing
By Ron Shinkman, Editor, Laboratory Industry Report Invivoscribe Technologies, a San Diego-based laboratory and equipment supplier, has entered into a companion testing pact with Astellas Pharma, Inc. The deal will focus primarily on developing a diagnostic test...
Update: New Study Credits Criminal Attacks as Source of Most Healthcare Data Breaches
By Kelly A. Briganti, Editorial Director, G2 Intelligence Last week, we referenced a 2014 study by Ponemon Institute that estimated the cost of a data breach to be around $200 per record in the United States, with the healthcare industry having one of the highest...
Quest Collaborates With French Researchers to Provide BRCA Variants Data
...
Register